MBC BioLabs

Asher Bio is an information technology company that specializes in the fields of CFO Office transformation, profitability, and cost management. It focuses on building and developing better immunotherapy for cancer. The company was founded in 2019 and headquartered in San Francisco, California.

Kit.com is a company that specializes in at-home medical testing solutions, providing health testing kits designed to facilitate preventative health assessments across various industries. By enabling insurers and telehealth companies to offer convenient testing options, Kit.com aims to enhance patient access to essential health services from the comfort of their homes. The company's offerings include comprehensive testing services that serve as safe and reliable alternatives to traditional doctor and laboratory visits. Additionally, Kit.com is involved in supplying a diverse range of products, including electronics and sporting goods, available for online shopping, thereby addressing customer inquiries through multiple channels such as phone, email, and online applications.

Keyhole Therapeutics is a discovery stage drug company specializing in immunotherapies for cancer and autoimmune diseases. Keyhole's first program, a small molecule inhibitor of exosome release being investigated for promotion of immune-driven tumor destruction in cancer patients resistant to current immune checkpoint inhibitors, is at the hit-to-lead stage. Future programs will include additional inhibitors of exosome release, and novel exosome-related therapeutic opportunities for cellular cancer vaccines and for targeted suppression of autoreactive T cells. Keyhole Therapeutics is seeking bold, accomplished, and innovative scientists to join them in pioneering the next wave of immunotherapeutics.

Jupiter Therapeutics is a biotechnology company that creates cell-membrane-based therapeutics. The company enables a synthetic biology approach enabling the rapid design and synthesis of a pipeline of assets focused on cancer, autoimmunity, drug delivery, and gene therapy.

Factorial Diagnostics is focused on leveraging its novel NGS library prep methods and bioinformatics algorithms to commercialize high resolution, multi-omic, cancer diagnostic assays.

Single Helix Genomics is a biotechnology company focused on the development of innovative solutions for the production of mRNA therapeutics and vaccines. It specializes in creating cGMP-compliant products, including both custom and pre-designed RNA, facilitated by a proprietary single-use microfluidic biochip. The company has engineered an automated and portable therapeutics-on-demand device that enables the small-scale, consistent manufacturing of therapeutics-grade mRNA within hours. By utilizing patent-protected hardware, software, and proprietary enzyme-based formulations, Single Helix Genomics offers the capability to produce personalized mRNA therapies and vaccines, allowing patients to access these treatments on demand, often in under two days.

Mission Bio, Inc. is a biotechnology company focused on advancing the study of cellular heterogeneity through its innovative Tapestri Platform, which is the first single-cell multi-omics platform. This platform allows for the simultaneous analysis of genotype and phenotype from individual cells, enabling precise detection of variations in disease progression and treatment responses. Utilizing proprietary microfluidic droplet technology, Mission Bio provides targeted solutions for high-impact applications in fields such as oncology, hematology, and genome editing. The company also offers Tapestri Designer, a cloud-based tool for creating custom single-cell DNA panels, enhancing its capabilities in research and clinical settings. Founded in 2011 and based in South San Francisco, California, Mission Bio was previously known as Torrent Bio, Inc. before rebranding in 2013.